Arcturus Therapeutics Holdings Inc. Total Assets

Quick Answer

Arcturus Therapeutics Holdings Inc. reported Total Assets of $271.15 million for fiscal year 2025.

Arcturus Therapeutics Holdings Inc. Total Assets — Annual History

Fiscal Year Total Assets YoY Change
2025 $271.15M -21.2%
2024 $344.07M -19.9%
2023 $429.40M -4.7%
2022 $450.39M +14.7%
2021 $392.81M -17.6%
2020 $476.46M +480.0%
2019 $82.14M +85.9%
2018 $44.20M

Quarterly Total Assets

Quarter Ending Total Assets YoY QoQ
September 30, 2025 $282.34M -23.8% -8.7%
June 30, 2025 $309.27M -20.4% -6.8%
March 31, 2025 $331.79M -20.8% -3.6%
December 31, 2024 $344.07M -19.9% -7.2%
September 30, 2024 $370.65M -19.0% -4.6%
June 30, 2024 $388.61M -9.8% -7.2%
March 31, 2024 $418.85M -11.0% -2.5%
December 31, 2023 $429.40M -4.7% -6.2%
  • Arcturus Therapeutics Holdings Inc. showed a decrease of -21.2% in Total Assets compared to the prior fiscal year.
  • Over the 2018–2025 period, Arcturus Therapeutics Holdings Inc.’s total assets has grown by 513.5% (from $44.20 million to $271.15 million).
  • The most recent figure is from Arcturus Therapeutics Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment